205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.52%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
-16.03%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.08%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.90%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.20%
Share reduction more than 1.5x MRVL's 0.48%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.10%
Diluted share count expanding well above MRVL's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-42.68%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-47.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
54.04%
10Y revenue/share CAGR above 1.5x MRVL's 19.04%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
24.84%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
23.53%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
107.34%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
102.79%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
86.39%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
179.18%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
330.89%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
121.75%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
36.24%
10Y equity/share CAGR at 75-90% of MRVL's 48.03%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
10.06%
5Y equity/share CAGR above 1.5x MRVL's 5.00%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
8.51%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
1145.59%
Dividend/share CAGR of 1145.59% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.66%
Dividend/share CAGR of 193.66% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.64%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
5.52%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
2.96%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.76%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.38%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-6.95%
We’re deleveraging while MRVL stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
7.58%
R&D growth drastically higher vs. MRVL's 0.65%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
6.81%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.